Novo Nordisk A/S vs Suncor Energy Inc. — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Suncor Energy Inc. trades at $63.65 (market cap $72.86B). The key difference: Novo Nordisk A/S is far larger — about 3× Suncor Energy Inc.'s market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | SU | |
|---|---|---|
Market Cap | $220.53B | $72.86B |
Sector | Health | Energy |
52-Week High | $71.70 | $69.73 |
52-Week Low | $35.29 | $38.17 |
Enterprise Value | $239.49B | $80.99B |
Dividend Yield | 3.63% | 2.71% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →